Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Background
About a third of the world’s population, concentrated in poorer regions of the world, may be infected with TB, which generally lies dormant until the carrier’s immunity is impaired by another disease (often HIV infection). Without treatment, about half of the patients with active TB will die. According to WHO...
If we can consider the facts about AIDS, as well as malaria and TB,then we can determine the true obstacles to treatment and eradication.
Millions in Africa and the rest of the developing world suffer from HIV/AIDS, malaria, and tuberculosis. What is the best way to treat them? Since President George W. Bush's pledge of $15 billion to fight these diseases, controversy has developed over strategies and methods. Last month at a conference in...
Knowing where all our ingredients come from is the first step toward improving drug quality.
A new initiative by Senator Tom Coburn could bringtransparency to the Global Fund to Fight HIV/AIDS, Tuberculosis, and Malaria.
The Global Fund to Fight AIDS, Tuberculosis, and Malaria will only be as effective as its procurement process allows.
Can the Health Impact Fund reward the makers of the best new drugs while keeping prices low? At this AEI event, experts will analyze the potential impact of this publicly funded program.
US government foreign assistance health programs are currently focused on combating HIV/AIDS, tuberculosis, and malaria, which account for several million deaths each year across Africa. The United States should prioritize sustaining the hard-won gains in disease control, which requires focusing on programs with proven track records of success and addressing failures within those programs.





